MY

Madhu Yadav

Active Director Director DIN 07210822
DIN 07210822 First appointment Jun 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2015
Shareholding value •••• Premium profile

About Madhu Yadav

Data last updated:

Madhu Yadav is a Director at Synoglad Pharmaceuticals Private Limited (since 2015). The company operates in Pharma. Synoglad Pharmaceuticals Private Limited reported revenue of ₹2.67 Cr (FY 2016).

DIN 07210822
Primary Designation Director
Industry Pharma
First Appointment 22 Jun 2015
Oldest Company Age 18 yrs
Largest company Synoglad Pharmaceuticals Private Limited · ₹2.67 Cr (FY 2016)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Jun 20152008₹2.67 Cr (FY 2016)Active

Board colleagues of Madhu Yadav

NameDINCompanyDesignation
Vikas Yadav02355863Synoglad Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Synoglad Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Madhu Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhu Yadav

Madhu Yadav currently holds 1 directorship: Synoglad Pharmaceuticals Private Limited (Director, since 22 Jun 2015, revenue ₹2.67 Cr (FY 2016)).

Madhu Yadav was first appointed on 22 Jun 2015 as Director at Synoglad Pharmaceuticals Private Limited.

The current boards of Madhu Yadav's companies include Vikas Yadav (Synoglad Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available